🇺🇸 ABBV — AbbVie Inc.

Healthcare Compra
← Volver

Precio actual

256,46 USD

Máx. histórico

267,47

37 días

Caída desde máximo

-4,12%

Rango 52 semanas

190,75 – 267,47

Variación hoy

-1,44%

Cierre anterior

260,21

Rango de hoy

255,61 – 258,91

Volumen hoy

4.701.126

Información
Nombre completo
AbbVie Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
57.000
PER ⓘ
72,45 (puede no estar actualizado)
Dividend yield
2,70% (puede no estar actualizado)
Precio objetivo analistas
276,59 USD (puede no estar actualizado)
Primera cotización
02/01/2013
Precio actualizado
hace 1 día
Sobre la empresa

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma bands; Juvederm Collection to treat volume loss in the temples, undereye, cheeks, chin, lips and lower face; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; Qulipta for episodic and chronic migraine; and Vyalev for the treatment of motor fluctuations, as well as Botox Therapeutic to treat chronic migraine, overactive bladder, spasticity, cervical dystonia, and other conditions. In addition, the company offers Ozurdex for visual impairment; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; and other eye care products, including Refresh/Optive, Xen, Durysta, and Restasis. Further, it provides Mavyret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Dividendos repartidos Total últimos 12 meses: 6,8300 USD · Yield: 2,66%
Fecha de pago Importe por participación
14/01/2019 1,0700 USD
12/10/2018 0,9600 USD
12/07/2018 0,9600 USD
12/04/2018 0,9600 USD
11/01/2018 0,7100 USD
12/10/2017 0,6400 USD
12/07/2017 0,6400 USD
11/04/2017 0,6400 USD
11/01/2017 0,6400 USD
12/10/2016 0,5700 USD
13/07/2016 0,5700 USD
13/04/2016 0,5700 USD
13/01/2016 0,5700 USD
13/10/2015 0,5100 USD
13/07/2015 0,5100 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
26/10/2015 50,17 52,48 49,35 51,87 +3,04% 6,24% 13.890.400
23/10/2015 49,41 51,73 48,64 50,34 +4,29% 6,25% 26.214.800
22/10/2015 53,88 54,44 45,45 48,27 -10,33% 16,69% 46.517.700
21/10/2015 55,28 55,61 53,07 53,83 -1,82% 4,59% 11.638.800
20/10/2015 56,15 56,38 54,63 54,83 -2,37% 3,12% 6.494.600
19/10/2015 56,29 56,70 55,69 56,16 -0,65% 1,79% 6.463.000
16/10/2015 56,29 56,97 55,79 56,53 +0,69% 2,10% 7.342.800
15/10/2015 54,32 56,20 53,85 56,14 +4,08% 4,33% 7.781.600
14/10/2015 54,09 54,62 53,57 53,94 +0,26% 1,94% 8.727.400
13/10/2015 55,17 55,36 53,71 53,80 -3,53% 2,99% 9.467.900
12/10/2015 55,80 56,27 55,52 55,77 +0,23% 1,34% 6.515.000
09/10/2015 56,18 56,50 55,47 55,64 -0,71% 1,83% 7.178.500
08/10/2015 55,13 56,16 54,80 56,04 +0,74% 2,47% 6.737.300
07/10/2015 54,85 56,55 53,91 55,63 +1,00% 4,81% 11.056.100
06/10/2015 56,26 56,67 53,96 55,08 -2,82% 4,82% 9.008.300
05/10/2015 56,39 56,95 55,44 56,68 +1,54% 2,68% 9.332.800
02/10/2015 53,87 55,85 53,72 55,82 +1,25% 3,95% 6.942.600
01/10/2015 54,68 55,23 53,93 55,13 +1,32% 2,38% 9.255.800
30/09/2015 53,54 54,50 53,36 54,41 +3,07% 2,13% 11.895.500
29/09/2015 53,10 54,19 51,88 52,79 +0,55% 4,35% 12.842.800
28/09/2015 55,39 55,43 52,34 52,50 -5,81% 5,58% 15.123.000
25/09/2015 57,84 57,88 55,08 55,74 -1,47% 4,84% 8.673.500
24/09/2015 56,93 57,48 55,92 56,57 -1,50% 2,74% 8.625.500
23/09/2015 57,90 58,40 57,15 57,43 -0,54% 2,16% 9.827.000
22/09/2015 58,17 58,26 56,91 57,74 -2,78% 2,32% 14.192.000
21/09/2015 61,24 61,74 59,29 59,39 -2,99% 4,00% 11.038.100
18/09/2015 59,42 61,83 58,97 61,22 +2,27% 4,81% 28.957.000
17/09/2015 59,56 60,92 59,39 59,86 +0,59% 2,57% 10.281.700
16/09/2015 59,50 59,64 58,63 59,51 +0,52% 1,70% 8.044.200
15/09/2015 58,98 59,44 58,37 59,20 +0,44% 1,81% 10.474.700